Specific protection of different normal tissues

Pharmacology and Therapeutics

Volumn 39, Issue 1-3, 1988, Pages 33-43

  Rasey, Janet S ^a   Spence, Alexander M ^a   Badger, Christopher C ^a,b   Krohn, Kenneth A ^a   Vera, David M ^c   Livesey, John C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE;

CANCER; HUMAN; PRIORITY JOURNAL; RADIATION PROTECTION; REVIEW;

AMIFOSTINE; ANIMAL; HUMAN; RADIATION INJURIES; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE DISTRIBUTION;

EID: 0023752341     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(88)90037-X     Document Type: Article

References (66)

1. Oxygen concentration and the OER for acutely or chronically thiol deficient cells
2. 131I-labeled anti-Thy 1.1 monoclonal antibody
3. Modification of stromal radiosensitivity by misonidazole and WR-2721
4. 2 and microvascular responses during glucose exposure
5. Chemical radioprotection and radiosensitization of mammalian cells growing in vitro
6. Correlation between the radiobiological oxygen constant, K, and the non-protein sulphydryl content of mammalian cells
7. Radioprotection of mouse skin by WR-2721: The critical influence of oxygen tension
8. Is radioprotection by WR-2721 restricted to normal tissues?
9. The x-ray sensitivity of Serratia marcescens
10. Modification of radiation lung damage in mice by WR-2721: Dependence on oxygen concentration
11. 2 tension: Implications for its mechanisms of action
12. Effects of radioprotectors on DNA damage and repair, proteins, and cell-cycle progression
13. Radiobiological and biochemical studies of thiophosphate radioprotective compounds related to cysteamine
14. Quantitation of the radiotherapeutic importance of naturally-hypoxic normal tissues from collated experiments with rodents using single doses
15. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation-induced leg contractures in mice
16. Radiation protection of rat parenchymal hepatocytes with S-2-(3-aminopropylamino)ethylphosphorothioic acid
17. Combined radiation-protective and radiation-sensitizing agents. II. Radiosensitivity of hypoxic or aerobic Chinese hamster fibroblasts in the presence cysteamine and misonidazole: Implications for the ‘oxygen effect’ (with appendix on calculation of dose-modifying factors)
18. m for radiosensitization at 0°C of thiol depletion by diethylmaleate pretreatment: Quantitative differences found using the radiation sensitizing agent misonidazole or oxygen
19. Progress in receptor radiopharmaceuticals
20. Chemical protection against ionizing radiation
21. 2: Its measurement and meaning (Introductory Paper)
22. Metabolism and transport of glutathione and other gamma-glutamyl compounds
23. Protection of spermatogonial survival and testicular function by WR-2721 against high and low doses of radiation
24. Radioprotection by WR-2721 by gamma-irradiated rat parotid gland Effect on gland weight and secretion of 8–10 days post-radiation
25. Protective effects of WR-2721 against radiation-induced injury of murine gut, testis, lung, and lung tumor nodules
26. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice
27. Effects of WR-3689 and WR-255591 on survival, DNA damage and repair and on cell kinetics
28. Low radioprotection by thiol in lung: The role of local tissue oxygenation
29. Sensitizers and protectors in clinical oncology
30. Radioprotection of tumor and normal tissues by thiophosphate compounds
31. Pharmacological aspects of ionizing radiation and of chemical protection in mammals
32. Interaction of cultured mammalian cells with WR-2721 and its thiol, WR-1065: Implications for mechansms of radioprotection
33. 35S-WR-2721 biodistribution
34. DNA repair as a probe of radiosensitivity and radioprotection
35. Comparative physiology of the oxygen supply (Introductory paper)
36. Characterization of the asialoglycoprotein receptor in a continuous hepatoma line
37. WR-2721 and WR-1065 pharmacokinetics in mice
38. Equilibrium dialysis studies of the binding of radioprotector compounds to DNA
39. Radioprotection by WR-2721 against long-term chronic damage to the rat parotid gland
40. Short-term radioprotective effects of WR-2721 on the rat parotid glands
41. Radioprotection in rat spinal cord with WR-2721 following cerebral lateral intraventricular injection
42. Radioprotection in rat spinal cord with WR-2721 WR-77913 and WR-3689 following cerebral lateral ventricular or intracisternal administration
43. Radioprotection of mouse skin by WR-2721 in single and fractionated treatments
44. Hepatic binding protein: The galactose specific receptor of mammalian hepatocytes
45. The oxygen dependence of protection by aminothiols: Implications for normal tissues and solid tumors
46. The time course of radioprotection by WR-2721 in mouse skin
47. WR-2721 protection of pneumonitis and fibrosis in mouse lung after single doses of x rays
48. Radioprotection of oral cavity structures by WR-2721
49. 35S-labeled WR-2721 in normal and malignant tissues of the mouse
50. Protection of normal tissues by WR-2721 during fractionated irradiation
51. Protection of normal tissue against late radiation injury by WR-2721
52. Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721
53. The influence of oxygen on the induction of radiation damage in DNA in mammalian cells after sensitization by intracellular glutathione depletion
54. Tc-99m-galactosyl-neoglycoalbumin: In vivo characterization of receptor-mediated binding to hepatocytes
55. Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: Dependence on tumor type, drug dose and species
56. Prediction of the effective radioprotective dose of WR-2721 in humans through an interspecies tissue distribution study
57. 2 in heart and skeletal muscle
58. 2 and its regulation in resting skeletal muscle of the guinea pig
59. Modification of the radiation response of the mouse kidney by misonidazole and WR-2721
60. Free radical repair mechanisms and the interactions of glutathione and vitamin C and E
61. Model for specific rescue of normal hetatocytes during methotrexate treatment of hepatic malignancy
62. Variation in normal tissue responsiveness to WR-2721